| Literature DB >> 24582102 |
Alexander Bystritsky1, Jessica Danial2, David Kronemyer3.
Abstract
Anxiety or depression may be a risk factor for the development of diabetes. This relationship may occur through a combination of genetic predispositions; epigenetic contingencies; exacerbating conditions such as metabolic syndrome (a precursor to diabetes); and other serious medical conditions. Medications used to treat anxiety and depression have significant side effects, such as weight gain, further increasing the possibility of developing diabetes. These components combine, interact, and reassemble to create a precarious system for persons with, or predisposed to, diabetes. Clinicians must be aware of these interrelationships to adequately treat the disease.Entities:
Keywords: Anxiety; Cognitive behavioral therapy; Cognitive restructuring; Depression; Diabetes
Mesh:
Year: 2013 PMID: 24582102 DOI: 10.1016/j.ecl.2013.10.001
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741